• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

加纳非胰岛素依赖型糖尿病患者的总抗氧化状态

Total antioxidant status in non-insulin-dependent diabetes mellitus patients in Ghana.

作者信息

Dosoo D K, Rana S V, Offe-Amoyaw K, Tete-Donkor D, Maddy S Q

机构信息

Department of Chemical Pathology, University of Ghana Medical School, Accra, Ghana.

出版信息

West Afr J Med. 2001 Jul-Sep;20(3):184-6.

PMID:11922148
Abstract

Total antioxidant status (TAS) was measured in thirty-five (35) non-insulin-dependent diabetes mellitus (NIDDM) patients aged 40 to 65 (mean +/- SE 49.6 +/- 1.0) years. Patients were on diet and oral hypoglycaemic drug (Daonil) therapy with fasting plasma glucose (FPG) >7.8mmol/l. Similar measurements were carried out in thirty-four apparently healthy individuals within the same age range (mean + SE 46.3 +/- 1.1 years) and FPG <6.4 mmol/L. FPG was measured by glucose oxidase method and TAS by colorimetric method. Comparing the two groups, TAS was significantly reduced in the NIDDM patients (p<0.001). An inverse correlation between FPG and TAS suggests the existence of lower antioxidant defence in uncontrolled NIDDM. A good control of FPG accompanied with antioxidant therapy could help reduce free radical activity and minimise complications associated with increased free radical activity in diabetic patients.

摘要

对35名年龄在40至65岁(平均±标准误 49.6±1.0岁)的非胰岛素依赖型糖尿病(NIDDM)患者测定了总抗氧化状态(TAS)。这些患者采用饮食和口服降糖药(达美康)治疗,空腹血糖(FPG)>7.8mmol/l。对34名年龄范围相同(平均+标准误 46.3±1.1岁)且FPG<6.4 mmol/L的明显健康个体进行了类似测量。FPG采用葡萄糖氧化酶法测定,TAS采用比色法测定。比较两组发现,NIDDM患者的TAS显著降低(p<0.001)。FPG与TAS之间的负相关表明,未得到控制的NIDDM患者存在较低的抗氧化防御能力。良好地控制FPG并辅以抗氧化治疗有助于降低自由基活性,并将糖尿病患者因自由基活性增加而引发的并发症降至最低。

相似文献

1
Total antioxidant status in non-insulin-dependent diabetes mellitus patients in Ghana.加纳非胰岛素依赖型糖尿病患者的总抗氧化状态
West Afr J Med. 2001 Jul-Sep;20(3):184-6.
2
Total antioxidant status in type 2 diabetic patients: experience at University College Hospital (UCH) Ibadan, Nigeria.2型糖尿病患者的总抗氧化状态:尼日利亚伊巴丹大学学院医院(UCH)的经验
Niger J Clin Pract. 2007 Jun;10(2):126-9.
3
Plasma lipid peroxidation and antioxidiant nutrients in type 2 diabetic patients.2型糖尿病患者的血浆脂质过氧化和抗氧化营养素
J Med Assoc Thai. 2006 Nov;89 Suppl 5:S147-55.
4
Effects of metabolic control and vascular complications on indices of oxidative stress in type 2 diabetic patients.代谢控制和血管并发症对2型糖尿病患者氧化应激指标的影响。
Diabetes Res Clin Pract. 2005 Jun;68(3):207-16. doi: 10.1016/j.diabres.2004.10.004. Epub 2004 Dec 10.
5
Nicotinamide effects oxidative burst activity of neutrophils in patients with poorly controlled type 2 diabetes mellitus.烟酰胺对2型糖尿病控制不佳患者中性粒细胞的氧化爆发活性有影响。
Exp Diabesity Res. 2004 Apr-Jun;5(2):155-62. doi: 10.1080/15438600490424244.
6
Evaluation of oxidative stress in diabetic patients after supplementation with a standardised red orange extract.补充标准化红橙提取物后糖尿病患者氧化应激的评估。
Diabetes Nutr Metab. 2002 Feb;15(1):14-9.
7
Plasma antioxidants and type 2 diabetes mellitus.血浆抗氧化剂与2型糖尿病
Res Commun Mol Pathol Pharmacol. 2001;109(5-6):309-18.
8
Parameters of antioxidative defense in type 2 diabetic patients with cardiovascular complications.伴有心血管并发症的2型糖尿病患者的抗氧化防御参数
Ann Med. 2005;37(8):613-20. doi: 10.1080/07853890500330193.
9
Oxidative DNA damage and plasma antioxidant capacity in type 2 diabetic patients with good and poor glycaemic control.血糖控制良好和不佳的2型糖尿病患者的氧化DNA损伤与血浆抗氧化能力
Mutat Res. 2008 Feb 1;638(1-2):98-102. doi: 10.1016/j.mrfmmm.2007.09.002. Epub 2007 Sep 14.
10
Performance indicators and validity of serum fructosamine assay as a diagnostic test in a screening program for diabetes mellitus.血清果糖胺检测作为糖尿病筛查项目诊断试验的性能指标及有效性
Saudi Med J. 2003 May;24(5):477-84.

引用本文的文献

1
Effects of aqueous leaf extract in alloxan induced diabetic mice.水提叶提取物对四氧嘧啶诱导的糖尿病小鼠的影响。
Interv Med Appl Sci. 2016 Sep;8(3):109-117. doi: 10.1556/1646.8.2016.3.7.